Education
About Us
Working with TipRanks
Follow Us
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.69M | $ 7.88M | $ 5.73M | $ 1.26M | $ 231.00K |
| Gross Profit | $ 5.51M | $ 5.99M | $ 838.00K | $ -2.41M | $ -40.13M |
| Operating Income | $ -73.05M | $ -76.20M | $ -90.32M | $ -92.79M | $ -49.18M |
| EBITDA | $ -66.45M | $ -74.34M | $ -88.66M | $ -91.59M | $ -48.57M |
| Net Income | $ -63.12M | $ -69.20M | $ -85.88M | $ -104.39M | $ -72.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 47.32M | $ 102.19M | $ 168.89M | $ 186.22M | $ 22.84M |
| Total Assets | $ 99.63M | $ 159.78M | $ 227.81M | $ 307.72M | $ 46.54M |
| Total Debt | $ 25.21M | $ 20.22M | $ 22.61M | $ 24.36M | $ 10.88M |
| Net Debt | $ 18.00M | $ 9.41M | $ 13.37M | $ -3.03M | $ 5.33M |
| Total Liabilities | $ 42.43M | $ 47.04M | $ 56.30M | $ 57.60M | $ 151.49M |
| Stockholders' Equity | $ 57.20M | $ 112.74M | $ 171.51M | $ 250.12M | $ -104.95M |
| Cash Flow | |||||
| Free Cash Flow | $ -61.33M | $ -69.73M | $ -78.46M | $ -59.40M | $ -50.57M |
| Operating Cash Flow | $ -61.29M | $ -69.53M | $ -76.50M | $ -57.07M | $ -47.31M |
| Investing Cash Flow | $ 57.58M | $ 71.04M | $ 57.86M | $ -232.20M | $ -20.59M |
| Financing Cash Flow | $ 108.00K | $ 253.00K | $ 503.00K | $ 311.11M | $ 39.60M |